The World Health Organization (WHO) announced an unprecedented agreement to promote the production of technology to detect Covid antibodies to help poorer countries fight the pandemic and resolve “destructive inequality.”
When the WHO announced the agreement on Tuesday, it said that it will provide poor and middle-income countries with serological technology to detect Covid-19 antibodies free of charge.
WHO Director-General Ghebreyesus said the move is to “Reverse the tide of this pandemic and the devastating global inequality caused by this pandemic.”
This is the kind of open and transparent permit we need to move needles during and after the pandemic.
“The purpose of this license is to promote the rapid manufacturing and commercialization of CSIC’s COVID-19 serological test globally,” WHO said in a press release, adding that the proposal for low- and middle-income countries “It will remain valid until the last patent expires.”
The global agreement reached with the Spanish National Research Council (CSIC) will provide the test as a global public product under a test license signed by the WHO Pharmaceutical Patent Pool (MPP).
The international health agency said that even in rural areas with basic laboratory infrastructure, countries can use the technology to help detect the spread of the virus.
According to the World Health Organization, the Covid-19 pandemic has resulted in more than 256 million confirmed cases and more than 5.1 million deaths. To date, more than 7.4 billion doses of the Covid-19 vaccine have been vaccinated globally.
If you like this story, share it with your friends!